Massive R&D Ramp-Up
R&D expenses surged 244.7% year-over-year to $27.0M in Q1 2026 from $7.8M in Q1 2025, reflecting Oklo's aggressive investment in its advanced fission reactor technology development ahead of any commercial revenue generation.
Oklo Inc. is expected to release its Q2 2026 10-Q filing on August 18, 2026. Last quarter: Oklo reported a dramatically widened net loss of -$33.1M in Q1 2026 (vs. -$9.8M a year ago) driven by a 244.7% surge in R&D spending, while its balance sheet expanded nearly 8x to $2.7B in total assets following a major financing event that raised over $1.18B in cash.
EPS Estimate
$-0.16
Revenue Estimate
$128,775
Analyst consensus from Finnhub. Actual results posted within minutes of the SEC filing on the OKLO page.
Drawn from management commentary in the Q1 2026 10-Q:
R&D expenses surged 244.7% year-over-year to $27.0M in Q1 2026 from $7.8M in Q1 2025, reflecting Oklo's aggressive investment in its advanced fission reactor technology development ahead of any commercial revenue generation.
Operating loss deepened to -$51.2M from -$17.9M in the prior-year period, a deterioration of 186.7%, as the company continues to operate in a pre-revenue stage with rapidly escalating operating costs.
Financing cash flow reached $1.18B in Q1 2026 compared to essentially zero in Q1 2025, indicating a major equity or debt capital raise that has fundamentally reshaped the company's balance sheet and extended its operational runway.
EPS (Basic)
$-0.19
-171.43% YoY
Operating Income
$-51.25M
-186.72% YoY
Add OKLO to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.